Moxifloxacin Difluoro Acidum Impuritas CAS 93107-30-3 Puritas >99.0% (HPLC)
Ruifu Chemicum est primarium fabrica 1-Cyclopropyl-6,7-Difluoro-1,4-Dihydro-4-Oxoquinoline-3-Carboxylicum Acidum (CAS: 93107-30-3) cum qualitate alta.Ruifu Chemical traditio totius terrarum, quantitatis competitive pretium, optimum servitium, parvas et moles in promptu habere potest.Emptio,Please contact: alvin@ruifuchem.com
| Nomen chemicum | 1-Cyclopropyl-6,7-Difluoro-1,4-Dihydro-4-Oxoquinoline-3-Acidum carboxylicum |
| Synonyma | 1-Cyclopropyl-6,7-Difluoro-4-Oxo-1,4-Dihydroquinolino-3-Carboxylico Acid;Moxifloxacin Difluoro Acidum Impuritas;Moxifloxacin Impuritas 24 |
| Stock Status | In Stock, Commercial Productio |
| CAS Number | 93107-30-3 |
| Formulae hypotheticae | C13H9F2NO3 |
| M. Pondus | 265.22 |
| Liquescens punctum | 289°C(lit.) |
| Density | 1.630±0.06 g/cm3 |
| COA & MSDS | Praesto |
| Sample | Praesto |
| Origin | Shanghai, China |
| Brand | Ruifu Chemical |
| Items | Specifications | Proventus |
| Aspectus | Off-White ad lactis colorem pulveris | Conforms |
| Puritas / Analysis Methodus | >99.0% (HPLC) | 99.78% |
| Principalis Una immunditia | <0.50% | 0.20% |
| Damnum in Siccatio | <0.50% | 0.06% |
| Residere in Ignition | <0.20% | 0.04% |
| 1H NMR Imaginum | Conformat ut Structure | Conforms |
| LC-MS pro Lepidium sativum | Conforms | Conforms |
| conclusio | Productum probatum est et cum datis specificationibus obsequitur | |
Sarcina:Fluorinated Utrem, aluminium ffoyle, 25kg/cardboard Drum, vel secundum exigentiam emptoris.
Repono Condition:Continentem arcte clausam et in loco frigido, sicco (2~8℃) reponunt et a cellis bene ventilatis ab substantiis incompossibilibus.A luce et humore protege.
Naviportans:Libera ad mundum ab aere, per FedEx / DHL Express.Ieiunium et certas traditiones provide.
Quam mercari?Quaeso contactumDr. Alvin Huang: sales@ruifuchem.com or alvin@ruifuchem.com
15 Years Experience?Plus quam XV annos experientiae habemus in fabricando et exportando amplis intermediis pharmaceuticis vel alchimicis pharmaceuticis amplis.
Mercatus principalis?Vendere mercatum domesticum, Americam septentrionalem, Europam, Indiam, Coream, Iaponicam, Australiam etc.
Commodi?Superior qualitas, parabilis pretium, officia professionalia et subsidia technica, ieiunium partus.
Qualitasfides?Qualitas strictioris temperantiae ratio.Pro instrumento analysi professionali includuntur NMR, LC-MS, GC, HPLC, ICP-MS, UV, IR, OR, KF, ROI, LOD, MP, Claritas, Solubilitas, Microbialis limes test, etc.
Exempla?Pleraque producta praebent exempla gratuita pro qualitate aestimationis, sumptus naviculas a clientibus solvendos.
Factory Audit?Factory audit gratissimum.Quaeso ante constitutum.
MOQ?Nec MOQ.Parvus ordo placet.
Tempus adferendi? Si intus prosapia, tres dies partus praestatur.
Transportatio?Per Express (FedEx, DHL), ab Air, per Mare.
Documenta?Post servitium venditionis: COA, MOA, ROS, MSDS, etc. praeberi possunt.
Consuetudo Synthesis?Consuetudo synthesis officia praebere potest ad optimas investigationes tuas necessitates aptandas.
Pensio conditio?Proforma cautionis primum post confirmationem ordinis mittetur, informationes nostrae ripae inclusas.Payment by T/T (Telex Transfer), PayPal, Western Union, etc.
Periculosam symbola Xn - Noxia
Risk Codes R62 - Possibile periculum imminutae fertilitatis
R52/53 - Organismis aquaticis noxius, effectus contrarios in aquatilium environment causare potest.
Safety Description S22 - Pulverem ne respirare.
S36/37 - indumentis tutelae idoneis gere et caestus.
S61 - Vitanda remissionis ambitus.Refer ad peculiares instructiones / salus data chartis.
1-Cyclopropyl-6,7-Difluoro-1,4-Dihydro-4-Oxoquinolino-3-Carboxylico Acidum (Moxifloxacin Difluoro Acid Impuritas) (CAS: 93107-30-3) Impuritas Moxifloxacin est.Moxifloxacin synthetica fluoroquinolone-generatio est agentis antibacterialis, quae a Bayer AG (initio 12-8039 dicta est), tractabat plures infectiones, inter quas: tractus respiratorii infectiones, cellulitis, anthrax, infectiones intraabdominis, endocarditis, meningitis et tuberculosis. .Orbis terrarum (sicut in hydrochloride) notis nominibus Avelox, Avalox, et Avelon venale tractandi oralis est.In plerisque regionibus medicamentum etiam in forma parenterali pro infusione intravenosa praesto est.
